Estimates Revisions Haemonetics Corporation
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
16:00:03 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 102.84 USD | -0.08% |
|
+0.87% | +28.31% |
| 08-19 | Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating | MT |
| 08-18 | Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- HAE Stock
- Consensus Haemonetics Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
